Extended Release Bupivacaine Hydrochloride Resorbable Matrix Formulation

**Semantic type:** Organic Chemical|Pharmacologic Substance

**Definition:** An extended release (ER) injectable formulation composed of the hydrochloride salt form of bupivacaine, an amide-type, long-acting local anesthetic, in a resorbable sucrose acetate isobutyrate-based matrix, with analgesic activity. Following administration in or around a specific site, ER bupivacaine is released from the matrix over an extended period of time. Upon release, bupivacaine reversibly binds to specific voltage-gated sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions, membrane destabilization, and depolarization inhibition thus disrupting nerve impulse conduction. This eventually leads to a reversible loss of sensation. This formulation may provide pain relief up to 72 hours.

**Synonyms:** - ER Bupivacaine HCl - SABER-Bupivacaine Hydrochloride - Sustained Release Bupivacaine Hydrochloride